United States Government Publishing Office publisher pbl distributor dst United States Government Accountability Office author aut Government Organization text government publication eng GAOREPORTS Legislative Agency Publications gao legislative 2010-08-12 U.S. Government Printing Office 2007-06-21 monographic deposited born digital 15 p. GA 1.13:GAO-07-1022T https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-1022T P0b002ee18037669c f:d071022t DGPO 2010-08-12 2011-03-23 GAOREPORTS-GAO-07-1022T machine generated eng fdlp REPORT GAOREPORTS-GAO-07-1022T GAO-07-1022T Beneficiaries Claims processing Eligibility determinations Health care programs Internal controls Medicaid Medicare Monitoring Pharmaceutical industry Prescription drugs Prospective payments Reimbursements Testimony A71185 Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), dual-eligible beneficiaries--individuals with both Medicare and Medicaid coverage--have their drug costs covered under Medicare Part D rather than under state Medicaid programs. The MMA requires the Centers for Medicare & Medicaid Services (CMS) to enroll these beneficiaries in a Medicare prescription drug plan (PDP) if they do not select a plan on their own. CMS enrolled about 5.5 million dual-eligible beneficiaries in late 2005 and about 634,000 who became dually eligible during 2006. GAO was asked to testify on (1) CMS's process for enrolling new dual-eligible beneficiaries into PDPs and its effect on access to drugs and (2) how CMS set the effective coverage date for certain dual-eligible beneficiaries and its implementation of this policy. This testimony is based on the GAO report, Medicare Part D: Challenges in Enrolling New Dual-Eligible Beneficiaries (GAO-07-272). https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-07-1022T/html/GAOREPORTS-GAO-07-1022T.htm https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-07-1022T/pdf/GAOREPORTS-GAO-07-1022T.pdf GAO-07-1022T https://www.govinfo.gov/app/details/GAOREPORTS-GAO-07-1022T Testimony GAO-07-1022T; Medicare Part D: CMS's Process and Policy for Enrolling New Dual-Eligible Beneficiaries; Beneficiaries Claims processing Eligibility determinations Health care programs Internal controls Medicaid Medicare Monitoring Pharmaceutical industry Prescription drugs Prospective payments Reimbursements Volume 117 Page 2066 117 Stat. 2066 Public Law 108-173